Pharma Mar It has managed to pierce the resistance of 6.26 euros, which is a sign of strength that invites us to think about an extension of earnings to the level of 6.80 euros, prices that could be reached in the coming days.
Let us advise you on your investments. Try Trader Watch free 7 days. In the last year we accumulated a revaluation of 217.20%.
4.23% falls in Corporation Income Losing the support of 1.91 euros complicated their short-term technical prospects. Note that for the next few days it is very likely that we can end up seeing an extension of the falls to the level of 1.40 euros, annual lows.
2.03% falls in Ezentis which loses the short-term support it presents at 0.3240 euros. Note that for the next few days it is very likely that we can end up seeing a continuation of the falls to the level of 0.25 euros.